Currently, 18 million people are living with a diagnosis of cancer worldwide, and they will be 26 million by 2040
*
.
Although the great advances obtained by research have made it possible to increase the number of patients cured, 63.5% of them develop sequelae due to cancer or treatment *
*
and 50% of patients cured of pediatric cancer may suffer from severe or disabling complications after 45 years.
For a century, the Gustave-Roussy teams have been committed to fighting cancer, at all ages and at all stages of the disease.
A fight waged on several fronts, thanks to a synergy between research, care and teaching professionals united within a single global pole of expertise dedicated to patients.
A flagship of research ranked 1st in Europe (and 5th worldwide) in the fight against cancer in 2020, the Institute has chosen to devote one of its major medico-scientific projects to “post-cancer”.
Heal and live better
The post-cancer program, called "Interval", is a large-scale project aimed both at better preventing the onset of sequelae and late complications, as well as at supporting patients during and after their treatment course, for their benefit. ensure better healing, emotionally, physically and socially.
In addition to this ambition, there is the implementation of new personalized care pathways and the scientific evaluation of their clinical benefits.
In 2021, € 745,000 are essential to begin the missions of this unprecedented “post-cancer” program.
Each donation counts to support the action of Gustave-Roussy and its Foundation - private health establishments of collective interest authorized to receive donations and bequests - in the realization of this ambitious project of prevention and management of sequelae.
Placing your taxes at the service of innovations in cancer research and care means actively joining the fight for tens of thousands of patients treated each year at Gustave-Roussy and allowing them to resume their lives in better conditions.
All donations in favor of Gustave-Roussy and its Foundation lead to tax advantages, depending on the tax situation of each.
Thus, 75% of the amount is deductible from the IFI (within the limit of € 50,000), 66% of the donation is deductible from the IR (within the limit of 20% of taxable income) and 60% of the donation deductible from corporate tax (within the limit of 0.5% of turnover).
More information on the Interval and donation project online at:
www.gustaveroussy.fr/fr/don-apres-cancer
and on the IFI tax exemption
:
www.gustaveroussy.fr/fr/don-ifi
* Shapiro study, 2019
** Vican 5 study
